Summary: Marseille-Kliniken AG Aug 11

  • ID: 1860049
  • August 2011
  • Standard & Poors
1 of 3

The rating on Germany-based private health care provider Marseille-Kliniken AG (Marseille) reflects its highly leveraged financial profile, including high lease-adjusted debt levels and a less-than-adequate liquidity profile. The rating is supported by Marseille's good competitive position in highly fragmented markets and the predictable growth in future nursing-care needs. However, the market is subject to regulation, public price setting, and reimbursement negotiations with public insurance funds. Based in Berlin, Marseille is one of Germany's largest private nursing-care and rehabilitation service providers. It generated -141.6 million turnover in the first nine months of fiscal year 2011, which ended on June 30, 2011. Standard & Poor's Ratings Services believes that the sale of the rehabilitation division will likely improve the stability of Marseille's...

Companies mentioned in this report are: Marseille-Kliniken AG
Action: Review

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Marseille-Kliniken AG

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our


Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.